EUR 42.15
(3.69%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 39.13 Million | 24.33 Million | 21.81 Million | 28.08 Million | 15.07 Million | 8.82 Million |
Net Income | 29.53 Million | 36.78 Million | 45.21 Million | 20.35 Million | 12.06 Million | 6.6 Million |
Depreciation & Amortization | 6.25 Million | 7.44 Million | 5.84 Million | 4.32 Million | 3.11 Million | 2.15 Million |
Deferred income taxes | -995 Thousand | -557 Thousand | -806 Thousand | -563 Thousand | -159 Thousand | - |
Stock-based compensation | 995 Thousand | 557 Thousand | 806 Thousand | 563 Thousand | 159 Thousand | - |
Change in working capital | 7.8 Million | -5.37 Million | -20.9 Million | 2.47 Million | -15 Thousand | -1.37 Million |
Other non-cash items | -4.44 Million | -14.52 Million | -8.33 Million | 922 Thousand | -87 Thousand | 1.42 Million |
Investing Cash Flow | -5.83 Million | -3.43 Million | -19.22 Million | -20.6 Million | -1.77 Million | -1.6 Million |
Investments in PPE | -3.12 Million | -3.58 Million | -11.76 Million | -2.56 Million | -1.8 Million | -1.61 Million |
Acquisitions | -2.8 Million | 104 Thousand | -7.55 Million | -18.05 Million | 34 Thousand | 14 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 90 Thousand | 48 Thousand | 98 Thousand | 24 Thousand | 34 Thousand | 14 Thousand |
Financing Cash Flow | -17.58 Million | -11.29 Million | -14.71 Million | 8.91 Million | -10.78 Million | -7.29 Million |
Debt repayment | -1.93 Million | -20.88 Million | -56.76 Million | -19.29 Million | -13 Thousand | -78.87 Million |
Dividends payments | -11.95 Million | -11.2 Million | -9.51 Million | -7.1 Million | -6.91 Million | -3.36 Million |
Common Stock Repurchased | - | -312 Thousand | -2.51 Million | -1.02 Million | - | - |
Common Stock Issuance | - | -20.88 Million | - | - | - | 45 Million |
Other Financing Activities | -3.69 Million | 42.1 Million | 54.1 Million | -2.24 Million | -3.85 Million | 29.94 Million |
Accounts receivables | -1.39 Million | 495 Thousand | -2.05 Million | 750 Thousand | -1.89 Million | 497 Thousand |
Accounts payables | -912 Thousand | -5.01 Million | 3.71 Million | 4.17 Million | 1.13 Million | -2.24 Million |
Inventory | 10.1 Million | -852 Thousand | -22.57 Million | -2.44 Million | 750 Thousand | 374 Thousand |
Other working capital | -912 Thousand | - | - | - | - | -1.74 Million |
Cash at beginning of period | 25.31 Million | 15.48 Million | 27.32 Million | 10.87 Million | 8.26 Million | 8.34 Million |
Cash at end of period | 40.58 Million | 25.31 Million | 15.48 Million | 27.32 Million | 10.87 Million | 8.26 Million |
Capital Expenditure | -3.12 Million | -3.58 Million | -11.76 Million | -2.56 Million | -1.8 Million | -1.61 Million |
Effect of forex changes on cash | -447 Thousand | 218 Thousand | 285 Thousand | 51 Thousand | 94 Thousand | 3000.00 |
Net cash flow / Change in cash | 15.27 Million | 9.82 Million | -11.83 Million | 16.44 Million | 2.61 Million | -77 Thousand |
Free Cash Flow | 36.01 Million | 20.74 Million | 10.05 Million | 25.51 Million | 13.26 Million | 7.2 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 5.86 Million | 7.47 Million | 29.53 Million | 8.21 Million | 6.07 Million | 6.96 Million |
Depreciation & Amortization | 1.61 Million | 1.6 Million | 6.25 Million | 1.61 Million | 1.54 Million | 1.54 Million |
Deferred income taxes | - | - | -995 Thousand | -995 Thousand | - | - |
Stock-based compensation | - | - | 995 Thousand | 995 Thousand | - | - |
Change in working capital | -4.96 Million | 1.66 Million | 7.8 Million | 5.77 Million | 405 Thousand | 493 Thousand |
Other non-cash items | 6.24 Million | 4.06 Million | -4.44 Million | -933 Thousand | -987 Thousand | -1.24 Million |
Investing Cash Flow | -542 Thousand | -2.24 Million | -5.83 Million | -3.8 Million | -959 Thousand | -778 Thousand |
Investments in PPE | -549 Thousand | -2.24 Million | -3.12 Million | -1.44 Million | -515 Thousand | -867 Thousand |
Acquisitions | 7000.00 | - | -2.8 Million | -2.35 Million | -444 Thousand | 89 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 7000.00 | - | 90 Thousand | 1000.00 | - | 89 Thousand |
Financing Cash Flow | -6.35 Million | -219 Thousand | -17.58 Million | -7.6 Million | -433 Thousand | -6.9 Million |
Debt repayment | -6000.00 | -12 Thousand | -1.93 Million | -846 Thousand | -14 Thousand | -6000.00 |
Dividends payments | -6.35 Million | - | -11.95 Million | -5.98 Million | - | -5.97 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -6000.00 | -13 Thousand | -3.69 Million | -779 Thousand | -419 Thousand | -928 Thousand |
Accounts receivables | -2.46 Million | -2.21 Million | -1.39 Million | 590 Thousand | 509 Thousand | 624 Thousand |
Accounts payables | 797 Thousand | 3.47 Million | -912 Thousand | 999 Thousand | -1.31 Million | -496 Thousand |
Inventory | -3.29 Million | 402 Thousand | 10.1 Million | 4.19 Million | 1.2 Million | 365 Thousand |
Other working capital | 798 Thousand | - | - | -1000.00 | 1000.00 | - |
Cash at beginning of period | 51.51 Million | 40.58 Million | 25.31 Million | 37.42 Million | 31.72 Million | 31.9 Million |
Cash at end of period | 45.38 Million | 51.51 Million | 40.58 Million | 40.58 Million | 37.42 Million | 31.72 Million |
Capital Expenditure | -549 Thousand | -2.24 Million | -3.12 Million | -1.44 Million | -515 Thousand | -867 Thousand |
Effect of forex changes on cash | 198 Thousand | 122 Thousand | -447 Thousand | -108 Thousand | 51 Thousand | -255 Thousand |
Net cash flow / Change in cash | -6.13 Million | 10.93 Million | 15.27 Million | 3.15 Million | 5.7 Million | -182 Thousand |
Free Cash Flow | 21 Thousand | 11.03 Million | 36.01 Million | 13.22 Million | 6.52 Million | 6.89 Million |
3708
VASO
CMH
WPFH
AAT
300218